Breast neoplasms
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. estrogen receptor >=10%, progesterone receptor >= 10% and epidermal growth factor receptor 2 negative; 2. proliferation index Ki-67 < 14%; 3. systemic therapy (chemotherapy, radiotherapy and endocrine therapy) in accordance with the National Comprehensive Cancer Network guidelines; 4. provision of informed consent of patients and their families.
Exclusion criteria
Exclusion criteria: 1. Bilateral breast cancer; 2. inflammatory breast cancer; 3. pregnancy or lactation; 4. history of other cancers or chest radiotherapy; 5. lymph node metastasis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease-free survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival;Total length of hospital stay;Average length of hospital stay per reexamination;Total cost of reexaminations;Average cost per reexamination; | — |
Countries
China
Contacts
Shengjing Hospital of China Medical University